Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hit Discovery Constance

Hit Discovery Constance
2013 FOUNDED
PRIVATE STATUS
Joint Venture LATEST DEAL TYPE
3 INVESTORS
Description

Provider of a compound management platforms intended to provide services to the life science industry. The company's compound management platforms offers a fully integrated service including cost effective design, optimization and validation of screening assays and running the entire screening campaign with all required compound logistics, enabling the life science industry to get all their compound management needs fulfilled.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Commercial Services
Primary Office
  • Byk-Gulden-Str. 2
  • 78467 Konstanz
  • Germany

+49 07531 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hit Discovery Constance’s full profile, request a free trial.

Hit Discovery Constance Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Joint Venture 01-Jan-2013 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Hit Discovery Constance Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Axxam Corporation Minority 000 0000 000000 0
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
Lead Discovery Center Corporation Minority 000 0000 000000 0

Hit Discovery Constance Executive Team (2)

Name Title Board
Seat
Contact
Info
Horst Flotow Ph.D Vertretungsberechtigter Geschäftsführer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »